(Q30627447)

English

Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

0 references

Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

0 references

adaptive radiation therapy

0 references

0 references

1 reference

based on heuristic

inferred from title

object named as

Audrey Mauguen

1

0 references

Suzanne E Dahlberg

object named as

Suzanne E Dahlberg

14

0 references

Steven E Schild

object named as

Steven E Schild

17

0 references

Stefan Michiels

object named as

Stefan Michiels

21

0 references

object named as

Chandra P Belani

8

0 references

Jean-Pierre Pignon

object named as

Jean-Pierre Pignon

2

0 references

Mary E. R. O'Brien

16

object named as

Mary O'Brien

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

Sarah Burdett

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Caroline Domerg

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

David Fisher

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Rebecca Paulus

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Samithra J Mandrekar

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Frances A Shepherd

9

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Tim Eisen

10

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Herbert Pang

11

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Laurence Collette

12

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

William T Sause

13

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Jeffrey Crawford

15

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Mahesh Parmar

18

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Jayne F Tierney

19

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Cécile Le Pechoux

20

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Surrogate Lung Project Collaborative Group

22

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

publication date

14 May 2013

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

14

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

619-626

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Cancer statistics, 2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Accelerated approval of oncology products: the food and drug administration experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Detecting an overall survival benefit that is derived from progression-free survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Individual- and trial-level surrogacy in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Progression-free survival is a surrogate for survival in advanced colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

20 June 2018

Overall survival: patient outcome, therapeutic objective, clinical trial end point, or public health measure?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

25 November 2018

Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

25 November 2018

Patterns of surgical care of lung cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

25 November 2018

The validation of surrogate endpoints in meta-analyses of randomized experiments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3732017

25 November 2018

Validation of surrogate end points in multiple randomized clinical trials with failure time end points

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970158-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970158-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23680111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23680111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S1470-2045(13)70158-X

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30627447&oldid=2104617215"